2010
DOI: 10.1007/s00705-010-0802-1
|View full text |Cite
|
Sign up to set email alerts
|

PCR diagnostics and monitoring of adenoviral infections in hematopoietic stem cell transplantation recipients

Abstract: After stem cell transplantation, human patients are prone to life-threatening opportunistic infections with a plethora of microorganisms. We report a retrospective study on 116 patients (98 children, 18 adults) who were transplanted in a pediatric bone marrow transplantation unit. Blood, urine and stool samples were collected and monitored for adenovirus (AdV) DNA using polymerase chain reaction (PCR) and real-time PCR (RT-PCR) on a regular basis. AdV DNA was detected in 52 (44.8%) patients, with mortality rea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
39
1
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(45 citation statements)
references
References 34 publications
(76 reference statements)
4
39
1
1
Order By: Relevance
“…Following HSCT, immunological responses to HAdV are poor; hence serological diagnosis is not reliable. Molecular identification of HAdV infection with PCR facilitates accurate and rapid diagnosis and can be used also for surveillance (Bil-Lula et al 2010;Ö hrmalm et al 2011). Weekly monitoring of different fluids of transplant recipients for active HAdV infection by real-time PCR (qPCR) could potentially be applied in HSCT recipients (Bil-Lula et al 2010;Matthes-Martin et al 2012).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Following HSCT, immunological responses to HAdV are poor; hence serological diagnosis is not reliable. Molecular identification of HAdV infection with PCR facilitates accurate and rapid diagnosis and can be used also for surveillance (Bil-Lula et al 2010;Ö hrmalm et al 2011). Weekly monitoring of different fluids of transplant recipients for active HAdV infection by real-time PCR (qPCR) could potentially be applied in HSCT recipients (Bil-Lula et al 2010;Matthes-Martin et al 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Molecular identification of HAdV infection with PCR facilitates accurate and rapid diagnosis and can be used also for surveillance (Bil-Lula et al 2010;Ö hrmalm et al 2011). Weekly monitoring of different fluids of transplant recipients for active HAdV infection by real-time PCR (qPCR) could potentially be applied in HSCT recipients (Bil-Lula et al 2010;Matthes-Martin et al 2012). Treatment of HAdV infection using ribavirin and/or cidofovir has not been proven in controlled trials yet, and their administration is limited by toxicity in adults (Lenaerts and Naesens 2006;Matthes-Martin et al 2012).…”
Section: Introductionmentioning
confidence: 99%
“…HKHT alı-cılarında ADV infeksiyonu insidansı %5 ile %32 arasında bildirilmiştir [13] . Çocuklarda ADV özellikle pnömoni ve hepatite sebep olur ve mortalite oranı %10-80'e kadar yüksek olabilir [14] . Kanda CMV, ADV ve EBV viral yükleri yükseldiğinde preemptif tedavi olarak antiviral ilaç tedavisi ve immünsüpresyonun azaltılması uygulanır.…”
Section: Discussionunclassified
“…In these situations, qPCR assay became very useful tool for the rapid, specific, and sensitive detection of HAdVs in different kind of samples (Bil-Lula et al 2010b). In addition to the promptness of detection, determination of the viral load is valuable because it may have predictive value for disseminated adenoviral disease (Claas et al 2005;Lion et al 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Quantitative or semiquantitative PCR assays allow also monitoring of the kinetics of the viral infection or effectiveness of antiviral treatment (Claas et al 2005). Quantification of HAdV DNA load has been suggested especially in patients who are at the greatest risk of dying from disseminated adenoviral infection (Bil-Lula et al 2010b;Claas et al 2005;Lion et al 2003), but treatment strategies supported with quantitative results of virus load monitoring with real-time PCR have not been validated by clinical trials so far.…”
Section: Introductionmentioning
confidence: 99%